Product Information
AMLODIPINE-ATORVAST 10-20 MG is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.8097 per EA under NDC 00378451893. Its NADAC has been published 646 times since Apr 9, 2014.
FDA first approved this application on Nov 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 20 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378451893
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMLODIPINE BESYLATE; ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA200465FDA Approved
11/29/2013
TE Code
AB
On Market Since
2/11/2014
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-ATORVAST 10-20 MG has been published 646 times since Apr 9, 2014, and over the history we have for it it has declined 87.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8097 per EA |
|---|---|
| All-time high | $6.9238 (Jul 16, 2014) |
| All-time low | $0.6922 (Jun 19, 2024) |
| 52-week high | $1.3995 |
| 52-week low | $0.8097 |
| Median price | $2.7053 |
| Average price | $3.1178 |
| Largest weekly change | +120.1% (Dec 21, 2022) |
| Weeks tracked | 646 |
| Tracking since | Apr 9, 2014 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Amlodipine and atorvastatin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMLODIPINE-ATORVAST 10-20 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-ATORVAST 10-20 MG, manufactured by Mylan Pharmaceuticals Inc., is $0.8097 per EA (NDC 00378451893), effective Aug 19, 2026.
How has the price of AMLODIPINE-ATORVAST 10-20 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-ATORVAST 10-20 MG has declined 87.9%. It has been tracked across 646 weekly CMS publications since Apr 9, 2014.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-ATORVAST 10-20 MG?
Since Apr 9, 2014, the NADAC for AMLODIPINE-ATORVAST 10-20 MG has ranged from a low of $0.6922 (Jun 19, 2024) to a high of $6.9238 (Jul 16, 2014), with a median of $2.7053 per EA.
Are there cheaper alternatives to AMLODIPINE-ATORVAST 10-20 MG?
No other NADAC-published product currently shares the active ingredient and strength of AMLODIPINE-ATORVAST 10-20 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AMLODIPINE-ATORVAST 10-20 MG?
AMLODIPINE-ATORVAST 10-20 MG (NDC 00378451893) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.